MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What's Behind the Recent Insider Selling at NewAmsterdam Pharma (NAMS)

2 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What's Behind the Recent Insider Selling at AnaptysBio

1 months ago

What's Behind the Recent Insider Selling at Vicor

5 days ago

What's Behind the Recent Insider Selling at International Seaways

1 months ago

What's Behind the Recent Insider Selling at GigaCloud Technology

1 months ago

CoreWeave Insider Dumps $370 Million in Stock After Brutal Sell-off

CoreWeave (CRWV) shareholder sold $370M in stock, intensifying investor scrutiny following a recent period of significant price declines. This large-scale divestment adds to a broader trend of insider...

CRWV

Stock News•3 days ago

NewAmsterdam Pharma Company N.V. (NAMS) Discusses Clinical Development Update and Interim Analysis Plans for PREVAIL Trial Transcript

NewAmsterdam Pharma (NAMS) provided a clinical development update regarding its ongoing PREVAIL trial. The company outlined specific plans for an interim analysis, which will serve as a key milestone ...

NAMS

Stock News•4 days ago

Insmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23%

Insmed shares fell 23% after Q1 sales missed analyst estimates, despite the company reporting 230% revenue growth. The decline follows investor disappointment regarding top-line performance, even as t...

INSM

Stock News•2 weeks ago

Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

ADMA Biologics (ADMA) is currently the subject of increased brokerage analyst attention regarding rating changes. Investors are evaluating the relevance of these sell-side recommendations as a potenti...

ADMA